English | Español
Patient Daily | Mar 16, 2026

FDA warns Novo Nordisk over unreported Ozempic safety events, including deaths
Patient Daily | Mar 16, 2026

Pharma faces fierce M&A competition as late-stage assets become scarce
Patient Daily | Mar 16, 2026

Study suggests matcha may reduce sneezing in people with nasal allergies
Patient Daily | Mar 16, 2026

Study links aging gut to cognitive decline in mice, suggests possible interventions
Patient Daily | Mar 16, 2026

Researchers identify mechanism explaining chemical disruption of sex hormones
Patient Daily | Mar 16, 2026

Study links dual-positive hybrid cells to shorter survival in advanced breast cancer
Patient Daily | Mar 16, 2026

Long-term study reveals lifelong challenges for children with single-ventricle heart disease
Patient Daily | Mar 16, 2026

Vanderbilt Health begins clinical trial for new implant to treat male urinary incontinence

Trending
+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'
+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
Patient Daily | Jun 12, 2026

Taxpayer advocate: 340B drug discount program offers 'perverse incentives'